These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 19181627)
1. Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-I. Rajakumar C; Ban MR; Cao H; Young TK; Bjerregaard P; Hegele RA J Lipid Res; 2009 Jun; 50(6):1223-8. PubMed ID: 19181627 [TBL] [Abstract][Full Text] [Related]
2. Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut. Collins SA; Sinclair G; McIntosh S; Bamforth F; Thompson R; Sobol I; Osborne G; Corriveau A; Santos M; Hanley B; Greenberg CR; Vallance H; Arbour L Mol Genet Metab; 2010; 101(2-3):200-4. PubMed ID: 20696606 [TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos. Lemas DJ; Wiener HW; O'Brien DM; Hopkins S; Stanhope KL; Havel PJ; Allison DB; Fernandez JR; Tiwari HK; Boyer BB J Lipid Res; 2012 Jan; 53(1):175-84. PubMed ID: 22045927 [TBL] [Abstract][Full Text] [Related]
7. Association of the Collins SA; Edmunds S; Akearok GH; Thompson JR; Erickson AC; Hildes-Ripstein E; Miners A; Somerville M; Goldfarb DM; Rockman-Greenberg C; Arbour L Front Pediatr; 2021; 9():678553. PubMed ID: 34295859 [No Abstract] [Full Text] [Related]
8. The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populations. Greenberg CR; Dilling LA; Thompson GR; Seargeant LE; Haworth JC; Phillips S; Chan A; Vallance HD; Waters PJ; Sinclair G; Lillquist Y; Wanders RJ; Olpin SE Mol Genet Metab; 2009 Apr; 96(4):201-7. PubMed ID: 19217814 [TBL] [Abstract][Full Text] [Related]
9. The apolipoprotein E polymorphism in Greenland Inuit in its global perspective. Gerdes LU; Gerdes C; Hansen PS; Klausen IC; Faergeman O; Dyerberg J Hum Genet; 1996 Nov; 98(5):546-50. PubMed ID: 8882873 [TBL] [Abstract][Full Text] [Related]
10. Genetic study of the Arctic CPT1A variant suggests that its effect on fatty acid levels is modulated by traditional Inuit diet. Senftleber N; Jørgensen ME; Jørsboe E; Imamura F; Forouhi NG; Larsen CL; Bjerregaard P; Hansen T; Albrechtsen A Eur J Hum Genet; 2020 Nov; 28(11):1592-1601. PubMed ID: 32561900 [TBL] [Abstract][Full Text] [Related]
11. Neonatal hypoglycemia and the CPT1A P479L variant in term newborns: A retrospective cohort study of Inuit newborns from Kivalliq Nunavut. Collins SA; Hildes-Ripstein GE; Thompson JR; Edmunds S; Miners A; Rockman-Greenberg C; Arbour L Paediatr Child Health; 2021 Jul; 26(4):218-227. PubMed ID: 34131458 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E and atherosclerosis in Greenland Inuit. Boudreau DA; Scheer WD; Malcom GT; Mulvad G; Pedersen HS; Jul E Atherosclerosis; 1999 Jul; 145(1):207-19. PubMed ID: 10428312 [TBL] [Abstract][Full Text] [Related]
13. Increased missense mutation burden of Fatty Acid metabolism related genes in nunavik inuit population. Zhou S; Xiong L; Xie P; Ambalavanan A; Bourassa CV; Dionne-Laporte A; Spiegelman D; Turcotte Gauthier M; Henrion E; Diallo O; Dion PA; Rouleau GA PLoS One; 2015; 10(5):e0128255. PubMed ID: 26010953 [TBL] [Abstract][Full Text] [Related]
14. The p.P479L variant in CPT1A is associated with infectious disease in a BC First Nation. Sinclair G; Collins S; Arbour L; Vallance H Paediatr Child Health; 2019 May; 24(2):e111-e115. PubMed ID: 30996616 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, Apo E and A4 polymorphism, and lifestyle. de Knijff P; Johansen LG; Rosseneu M; Frants RR; Jespersen J; Havekes LM Arterioscler Thromb; 1992 Dec; 12(12):1371-9. PubMed ID: 1450169 [TBL] [Abstract][Full Text] [Related]
16. Inuit metabolism revisited: what drove the selective sweep of CPT1a L479? Hale N Mol Genet Metab; 2020 Apr; 129(4):255-271. PubMed ID: 32088118 [TBL] [Abstract][Full Text] [Related]
17. CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis. Mørkholt AS; Trabjerg MS; Oklinski MKE; Bolther L; Kroese LJ; Pritchard CEJ; Huijbers IJ; Nieland JDV Sci Rep; 2019 Sep; 9(1):13299. PubMed ID: 31527712 [TBL] [Abstract][Full Text] [Related]
18. Carnitine palmitoyltransferase I and sudden unexpected infant death in British Columbia First Nations. Sinclair GB; Collins S; Popescu O; McFadden D; Arbour L; Vallance HD Pediatrics; 2012 Nov; 130(5):e1162-9. PubMed ID: 23090344 [TBL] [Abstract][Full Text] [Related]
19. Novel mutation in carnitine palmitoyltransferase 1A detected through newborn screening for a presymptomatic case in China: a case report. Gan Y; Yu F; Fang H Ital J Pediatr; 2021 Jul; 47(1):154. PubMed ID: 34233743 [TBL] [Abstract][Full Text] [Related]
20. Carrier frequency of a common mutation of carnitine palmitoyltransferase 1A deficiency and long-term follow-up in Finland. Roomets E; Polinati PP; Euro L; Eskelin PM; Paganus A; Tyni T J Pediatr; 2012 Mar; 160(3):473-479.e1. PubMed ID: 21962599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]